Specialist accountant for private surgeons in Paris: BNC 2035, CARMF, SELARL, aesthetic surgery VAT, SPFPL. Tax optimization and wealth planning. Quote within 24h.
Private surgeons — whether orthopedic, visceral, cardiovascular, plastic, neurosurgeons or maxillofacial specialists — face unparalleled fiscal, social and wealth complexity among healthcare professions. Your surgical fees frequently reach €200,000 to €500,000 per year, but your effective tax burden can be reduced by 30 to 50% with an adapted structure. Cabinet Hayot Expertise is the specialist chartered accountant for private surgeons in Paris who turns your tax pressure into a wealth management lever.
A chartered accountant for surgeons supports the private practitioner across all financial and fiscal dimensions: BNC 2035 declaration, optimization of surgical equipment depreciation, VAT compliance on aesthetic procedures, management of CARMF and URSSAF contributions, advice on transitioning to SELARL or SELAS, and wealth structuring via SPFPL and SCI. They transform the tax pressure of high liberal income into a measurable wealth strategy.
Virtually all private surgeons operate under the Non-Commercial Profits (BNC) regime with an obligation to file a 2035 declaration. The micro-BNC threshold (€83,600 in 2026) is structurally exceeded by surgeons: a sector 2 orthopedic surgeon in Paris receives an average of €350,000 to €450,000 in gross fees.
Immediate tax consequence: at €300,000 net profit, a surgeon as a sole proprietor pays:
Our intervention: with an optimized SELARL + SPFPL structure, the same surgeon can retain €150,000 to €180,000 in net disposable income — 2 to 2.5 times more — while building a lasting wealth structure.
Purely aesthetic procedures (cosmetic rhinoplasty, breast augmentation, facelifts, liposuction, cosmetic botox/hyaluronic acid injections) are subject to 20% VAT in France. Therapeutic or reconstructive procedures (post-cancer surgery, congenital malformations, trauma sequelae) remain VAT-exempt.
Our aesthetic surgery VAT audit classifies each procedure type, secures your CA3 declaration, and eliminates the risk of a back-tax audit covering up to 5 years.
Estimated CARMF + URSSAF breakdown for a surgeon with €250,000 BNC (2026):
| Body | Type | Estimated amount |
|---|---|---|
| CARMF — basic pension | Flat rate | ~€4,500/year |
| CARMF — supplementary ASV | Proportional | ~€15,000/year |
| CARMF — disability/death | Flat rate | ~€3,500/year |
| URSSAF — sickness-maternity | Proportional | ~€28,000/year |
| CSG/CRDS | Proportional | ~€35,000/year |
| Total | ~€86,500/year |
We handle all your surgical accounting: automated bank statement imports, CCAM fee reconciliation (including surcharges, modifiers U/F/P), clinic levy deduction, surgical equipment tracking, 2035 declaration preparation and electronic submission.
Real-time dashboard: via our Pennylane platform, you permanently visualize your cash flow, fee receipts (CPAM + insurers + patients), deductible expenses, and estimated taxes and contributions.
Key deductible expenses to maximize:
Madelin + PER combination: a surgeon with €300,000 BNC can deduct up to €104,000/year in pension/retirement contributions, saving up to €47,000/year in income tax.
When should a surgeon incorporate?
Incorporation is strongly recommended from €150,000 to €200,000 in net profit. The differential between IS (15-25%) and IR (41-45%) becomes material at this level.
SELARL vs SELAS for surgeons:
| Criterion | SELARL | SELAS |
|---|---|---|
| Social status | TNS (URSSAF + CARMF) | Assimilated employee |
| Social contributions on salary | ~45% | ~70% |
| Overall cost | Lower | Higher |
Our missions: valuation of liberal fund, drafting SELARL articles of association, Ordre des Médecins procedures, registration, asset contribution, IS accounting setup.
For a surgeon in SELARL generating €100,000 to €250,000 of annual IS profit, an SPFPL (Financial Participation Company for Liberal Professions) is the ultimate wealth structuring tool.
Concrete case — Dr. Laurent, orthopaedic surgeon, Paris 16th:
For surgeons with a consultation office, purchasing the premises via an SCI held by the SPFPL: rent paid by SELARL (IS-deductible), loan interest deductible from SCI results, build-up of transferable real estate assets.
| KPI | Formula | Sector target |
|---|---|---|
| Net BNC margin | Net profit / Gross income | 60-75% (excl. social contributions) |
| Effective IS/IR rate | Tax paid / Pre-tax profit | < 20% with optimized SELARL |
| RCP weight | RCP premium / Income | 5-15% (high-risk surgery) |
| Clinic levies | Block levies / Surgical fees | 10-20% |
| SPFPL dividend ratio | Dividends distributed to SPFPL / SELARL profit | 50-70% |
| Monthly net cash flow | (Net salary + Net dividends) / 12 | Variable by objective |
Beyond €200,000 in net profit, the absence of incorporation represents an excess tax cost of €80,000 to €150,000/year. Hayot Expertise handles the entire process in 4 to 6 weeks.
A plastic surgeon who does not charge VAT on purely aesthetic procedures risks a VAT audit covering 5 years of back taxes. Our aesthetic surgery VAT audit secures your declaration.
The CARMF calls provisional contributions based on year N-2 income, then regularizes in N+1 on actual income. A surgeon whose activity has grown strongly may receive a regularization bill of €20,000 to €50,000 at once. Our quarterly monitoring anticipates this.
Confusing "operating block usage fees" (deductible BNC expense) with "share of clinic profits" (dividend distribution, non-deductible) can trigger double taxation. We secure the correct qualification of all clinic-related flows.
✅ Specialist in high-income healthcare professions: BNC 2035, CARMF, URSSAF, aesthetic surgery VAT, SELARL, SPFPL mastered ✅ Digital automation: Pennylane platform with bank import, invoice OCR, real-time dashboard ✅ 24-hour responsiveness: reply within 24 hours (often within 4 hours) ✅ Quantified tax optimization: detailed SELARL vs BNC simulations, PER + Madelin strategy, SPFPL ✅ Complete wealth support: SPFPL, SCI, office premises purchase, practice transmission
Cabinet Hayot Expertise — 58 rue de Monceau, 75008 Paris 📞 Request a free discovery meeting — Response within 24h
Different surgical specialties produce very different financial profiles, and the right accounting structure depends on that profile.
Orthopaedic and trauma surgery typically generates the highest gross fees among Paris surgeons (€350-€500k per year for an established sector 2 surgeon), with significant clinic levies on operating-room usage (15-25% of fees). Implant supplier contracts, hardware kits and post-surgery follow-up structure the cash cycle. The SELARL + SPFPL combination is almost universal above €250k of net profit.
Plastic and aesthetic surgery carries the unique multi-VAT exposure described earlier: a single mixed practice (reconstructive + aesthetic) needs precise procedure-by-procedure classification. Aesthetic-only practices typically generate €400-€700k of fees, with VAT collected on most acts and a higher than average RC pro premium (€20-50k/year). Pre-treatment quotes, payment plans for cosmetic procedures and gift-voucher accounting all add complexity not seen in other specialties.
Visceral, digestive and neurosurgery combine high RC pro premiums (€30-€60k/year due to procedural risk) with often-lower volumes than orthopaedic surgery. The financial steering focuses on clinic-block coordination, hospital convention fees and the depreciation profile of any privately owned surgical equipment.
Cardiac, vascular and thoracic surgery typically operate in stricter hospital/clinic relationships, often with shared-block agreements that need careful accounting qualification. The high-pressure RCP premiums (often €40-€80k) require provisioning discipline.
A sector 1 surgeon (fully conventionné, no surcharges) benefits from a CPAM-financed portion of CARMF contributions (régime ASV) but is capped on official CCAM fees. A sector 2 surgeon (with surcharges) carries full CARMF cost but can adjust pricing within the limits of tact et mesure. The economic gap between the two sectors is significant (often €50-€150k of annual revenue), but the tax and contribution implications must be modelled together — a higher sector 2 income drives higher CARMF, URSSAF and IR brackets.
Retirement planning is a major topic. With marginal income tax rates at 45%, the Madelin retirement contract lets surgeons deduct up to ~€85,000/year (within statutory ceilings) from their taxable BNC, saving ~€38k/year in income tax. The PER (Plan Épargne Retraite) complements this with an additional ~€35k of deductible contributions. For a sector 2 surgeon generating €300k of net profit, the combined Madelin + PER strategy can reduce taxable BNC by €120k, saving roughly €54k/year in tax — a permanent annual lever.
When a private surgeon prepares retirement or sells their practice, two paths exist:
We coordinate the valuation, structure the deal for optimal tax outcome, and prepare the financing file for the buyer.
The annual tax cost of staying as a sole trader instead of moving to a SELARL + SPFPL structure ranges from €50,000 to €150,000 above the €250k profit mark. We model the transition every year for surgeons approaching the threshold.
"Operating-block usage fees" are a deductible BNC expense. "Share of clinic profits" is a dividend distribution and is not deductible. Confusing the two can trigger double taxation and a back-tax assessment. We secure the qualification of every clinic-related flow with the right contractual documentation.
A plastic surgeon who applies a single VAT treatment to all procedures risks a 5-year back-tax audit. Each procedure must be classified at the point of billing as therapeutic (VAT-exempt) or purely aesthetic (20% VAT), with the supporting medical justification archived in the patient file.
An SPFPL that simply holds cash year after year misses the tax-efficient compounding opportunity. We build a multi-year reinvestment plan covering office-premises SCI, life-insurance contracts within the holding, or partner buy-out funding.
RC pro premiums in high-risk specialties (orthopaedic, neuro, cardiac) have risen 5-10% per year since 2022. Surgeons who do not re-tender their cover every 2-3 years often overpay by €5,000-€15,000/year. We coordinate the re-tender with our broker network.
| KPI | Definition | Target |
|---|---|---|
| Fees per active month | Annual fees / Months worked | €25,000-€45,000 |
| RCP / fees | Annual RC pro premium / Annual fees | 5-15% |
| Clinic levies / fees | Block usage fees / Annual fees | 10-25% |
| BNC margin | Profit / Gross fees | 60-75% |
| Effective tax + social rate | (IR + URSSAF + CARMF) / Profit | < 35% with SELARL + Madelin |
| Cash available before drawings | EBITDA − tax provision − social provision − insurance | Monthly target |
| Madelin + PER usage rate | Annual contributions / Statutory ceiling | > 80% |
| SPFPL dividend yield | Dividends upstreamed / SELARL profit | 50-70% |
These indicators are reviewed quarterly with the surgeon, ensuring that every lever — clinic levy negotiation, retirement saving, dividend distribution — is calibrated to the year's actual fee trajectory. The combination of monthly accounting discipline, annual structural review and proactive social-contribution provisioning is what turns a high-fee surgical practice into a high-net-cash, transmissible asset that supports both the surgeon's near-term lifestyle and their long-term family wealth strategy. For sector 2 surgeons in particular, the structural levers compound across an entire career — €30-€50k saved annually translates to €1-€1.5 million of additional capital over 25 years of practice.
France has approximately 12,000 private surgeons, mostly operating under sector 2 (with fee surcharges). Main specialties: orthopedic-trauma surgery, visceral and digestive surgery, neurosurgery, cardiac and vascular surgery, plastic and aesthetic surgery, and maxillofacial surgery. Private surgeons mostly operate in private MCO clinics and maintain consultation offices. In 2026, outpatient surgery accounts for over 60% of all surgical procedures.
All private surgeons fall under the BNC regime with a mandatory 2035 declaration. The micro-BNC threshold (€83,600) is virtually always exceeded. Key deductible expenses: RCP, clinic levies, CARMF/URSSAF contributions, consultation equipment, CPD training, surgical journal subscriptions.
Purely aesthetic procedures (cosmetic rhinoplasty, breast augmentation, facelifts, liposuction, cosmetic botox/HA injections) are subject to 20% VAT. Therapeutic or reconstructive procedures remain VAT-exempt. Precise classification of each procedure type is essential to avoid VAT audits.
Surgeons contribute to CARMF for approximately €23,000/year at €250,000 BNC. Retirement optimization uses Madelin contracts (up to €69,632/year deduction) and PER (up to €35,000/year). Each euro contributed saves 41-45 cents of income tax.
Beyond €150,000-200,000 net profit, incorporation (SELARL + SPFPL holding) can halve the effective tax burden. IS (15-25%) replaces IR (41-45%) on undistributed profits. The SPFPL accumulates dividends with near-zero IS to finance real estate and succession planning.
Wherever you are in France, we deploy a 100% digital interface to deliver fast, highly-structured accounting and financial steering.
Samuel Hayot is a French chartered accountant and statutory auditor registered with the Paris professional bodies.
The firm is based in Paris 8 and operates with a delivery model designed for businesses located across France.
Pennylane, Dext, Silae and an automation-first setup built for visibility and speed.
Visible phone number, simple contact path, fast engagement letter and tighter qualification of the mandate.
30 complimentary minutes with Samuel Hayot to challenge your reporting and surface your priority levers.
Holding company, LMNP, startup, outsourced CFO: discover why a specialist accountant delivers far more than a generalist or an online accounting software.
French accounting and tax obligations vary significantly by sector. A chartered accountant specialised in your industry knows the sector plan of accounts, applicable collective agreements, specific tax regimes, and the performance indicators that matter to your business. Overview of 2026 specificities for construction, hospitality, medical liberal professions, e-commerce, real estate, transport and agriculture.
Incorporation into a SELARL is strongly recommended from €150,000 to €200,000 in net BNC profit. Beyond this threshold, the difference between corporate tax (IS at 15-25%) and income tax (IR at 41-45%) generates annual savings of €50,000 to €150,000. A surgeon with €280,000 net profit can go from €73,000 to €187,000 in annual disposable income with an optimized SELARL structure.
Yes, purely aesthetic procedures (cosmetic rhinoplasty, breast augmentation, facelifts, liposuction, cosmetic botox/hyaluronic acid injections) are subject to 20% French VAT. Therapeutic or reconstructive procedures (post-cancer surgery, congenital malformations, trauma sequelae) remain VAT-exempt. Misclassification can result in a VAT audit covering 5 years of back taxes, potentially amounting to €150,000-300,000 for an active plastic surgeon.
An SPFPL (Société de Participations Financières de Professions Libérales) is a medical holding company that owns the shares of your SELARL. It allows dividends to be received from the SELARL with near-zero taxation (parent-subsidiary regime: ~1.25% effective IS), then reinvested tax-free in real estate (SCI), financial markets, or to buy out retiring colleagues. For a surgeon generating €150,000 in dividends/year, the SPFPL enables accumulation of €1.5M in capital over 10 years with less than €20,000 in total intermediate taxation.
For a private surgeon with €250,000 of BNC profit, total CARMF + URSSAF contributions reach approximately €85,000-€90,000 per year. Provisioning 30-35% of monthly profit upfront is essential — the alternative is the classic January N+1 surprise when contributions are reassessed on the prior year's higher income. We model the provisioning calendar each year and adjust quarterly as fee patterns evolve.
At a 45% marginal income tax rate, the Madelin retirement contract lets surgeons deduct up to ~€85,000/year from taxable BNC. Combined with the PER (~€35,000/year), the strategy can reduce taxable BNC by ~€120k, saving roughly €54k of tax per year for a surgeon generating €300k of net profit. We calibrate the Madelin / PER mix annually based on income level, retirement horizon and liquidity needs.
For non-aesthetic specialties, the patient-base sale (cession de clientèle) typically values at 0.3×-0.5× of annual fees, higher for plastic and aesthetic surgery. For SELARL share sales, the company is valued on EBITDA multiples plus the patient base. Capital gains tax may be exempt under article 151 septies CGI for smaller practices, or treated under the 30% flat tax for SELARL shares. The Dutreil pact can apply to succession transfers, reducing donation rights by 75%.
Sector 1 surgeons are bound by official CCAM fees and benefit from CPAM-financed CARMF contributions. Sector 2 surgeons can apply surcharges within the *tact et mesure* limit but carry the full CARMF burden. The accounting difference is structural: sector 2 produces higher gross fees (€50-€150k more per year typically) but also higher CARMF, URSSAF and IR brackets. The net economic comparison must be modelled together with retirement strategy.
Chartered Accountant, registered with the Institute of Chartered Accountants.
Regulated French accounting and audit firm based in Paris 8, built to support companies across France with a digital and decision-oriented approach.